mini-GDE gene therapy (Genethon/INSERM)

N/A

Report date: 2025/05/19 16:53:06

Base Information

Drug Namemini-GDE gene therapy (Genethon/INSERM)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlycogen Storage Disease Type III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenethonInserm
China Registration ClassN/A

Develop Information

Active CompaniesInsermGenethon
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type III
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A